View by Specialty

Trending

DERM0325AAD_Barbieri _Graphic_01
March 13, 2025
4 min read
Save

FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide

Liver/Biliary Disorders News

SPONSORED CONTENT
March 20, 2025
3 min read
Save
Biomarkers identified by machine learning could assist in diagnosing liver diseases

Biomarkers identified by machine learning could assist in diagnosing liver diseases

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis, researchers reported.

SPONSORED CONTENT
March 18, 2025
2 min read
Save

‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

The addition of simvastatin plus rifaximin to standard therapy did not improve outcomes among patients with decompensated cirrhosis who were at high risk for clinical complications, according to a study published in JAMA.

SPONSORED CONTENT
March 17, 2025
2 min read
Save

Study: Live vaccines safe, effective in pediatric transplant recipients

Study: Live vaccines safe, effective in pediatric transplant recipients

Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective antibodies that persisted for up to a year after vaccination with no significant safety events, researchers found.

Trending

DERM0325AAD_Barbieri _Graphic_01
March 13, 2025
4 min read
Save

FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide

SPONSORED CONTENT
March 13, 2025
3 min read
Save

Normothermic machine perfusion boosts liver transplant outcomes, may expand donor criteria

Normothermic machine perfusion boosts liver transplant outcomes, may expand donor criteria

Normothermic machine perfusion was linked to significant improvements in liver transplant clinical outcomes and reduced hospital resource use, especially among patients who received donation after circulatory death allografts, data show.

SPONSORED CONTENT
March 06, 2025
2 min read
Save

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial

The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according to a study published in NEJM Evidence.

SPONSORED CONTENT
February 27, 2025
5 min read
Save

Q&A: ‘Unacceptable’ medical deserts leave rural patients with rare diseases stranded

Q&A: ‘Unacceptable’ medical deserts leave rural patients with rare diseases stranded

Approximately 14% of the U.S. population lives in rural areas, where access to health care may be limited by insurance coverage, geography and infrastructure, and provider shortages, according to HHS.

SPONSORED CONTENT
February 26, 2025
2 min read
Save

HCV testing guidelines tied to increased screening for pregnant women

HCV testing guidelines tied to increased screening for pregnant women

Despite decreased population-level hepatitis C virus screening in 2020, guidance to test all adults and during every pregnancy was associated with increased HCV screening for pregnant women, according to a research letter published in JAMA.

SPONSORED CONTENT
February 26, 2025
2 min read
Save

Metabolic surgery slashed risk for adverse outcomes in MASH-related cirrhosis, obesity

Metabolic surgery slashed risk for adverse outcomes in MASH-related cirrhosis, obesity

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated steatohepatitis, according to study data.

SPONSORED CONTENT
February 24, 2025
2 min read
Save

FMT safe, linked to reduced hepatic encephalopathy recurrence in patients with cirrhosis

FMT safe, linked to reduced hepatic encephalopathy recurrence in patients with cirrhosis

Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy recurrence among patients with cirrhosis receiving lactulose and rifaximin, according to a study in Journal of Hepatology.

SPONSORED CONTENT
February 21, 2025
2 min read
Save

Injectable naltrexone tops disulfiram, acamprosate as safer option in alcohol use disorder

Injectable naltrexone tops disulfiram, acamprosate as safer option in alcohol use disorder

Injectable naltrexone had a more favorable gastrointestinal and liver safety profile compared with other medications for alcohol use disorder, according to a research letter published in Clinical Gastroenterology and Hepatology.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails